Elanco Animal Health Inc (ELAN)

Industry Drug Manufacturers - Specialty & Generic


This stock can be held in an Investment ISA and an Investment Account
Sell

$11.73

Buy

$12.95

arrow-down$-0.02 (-0.15%)

Prices updated at 16 May 2025, 23:22 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Lawrence E. Kurzius
CEO
Mr. Jeffrey N. Simmons
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
9,450
Head office
2500 Innovation Way
Greenfield
United States
46140
mobile
+1 877 352-6261
letter
greffet_james_f@elanco.com

Key personnel

Salary
Mr. John P. Bilbrey
Independent Director
0.11m
Ms. Kathy V. Turner
Independent Director
0.07m
Mr. Craig Wallace
Independent Director
0.07m
Mr. Art A. Garcia
Independent Director
0.09m
Dr. Deborah T. Kochevar, D.V.M.,PhD
Independent Director
0.11m
Mr. Lawrence E. Kurzius
Chairman of the Board
0.19m
Mr. R. David Hoover
Independent Director
0.16m
Mr. Jeffrey N. Simmons
President, Chief Executive Officer and Director
1.20m
Mr. Paul S. Herendeen
Independent Director
0.09m
Mr. Michael J. Harrington
Independent Director
0.10m
Dr. Denise Vera Scots-Knight, PhD
Independent Director
0.09m
Ms. Kapila Kapur Anand
Independent Director
0.12m
Mr. Todd S. Young
Executive Vice President and Chief Financial Officer
0.69m
Mr. David S. Kinard
Executive Vice President, Human Resources, Corporate Communications and Administration
-
Mr. Ramiro Martin Cabral
Executive Vice President and President of Elanco International
0.62m
Mr. James M. Meer
Senior Vice President and Chief Accounting Officer
-
Mr. Kirk McDonald
Independent Director
0.10m
Mr. Timothy J. Bettington
Executive Vice President, Corporate Strategy and Market Development
0.64m
Mr. Jose Manuel Correia de Simas, PhD
Executive Vice President, U.S. Farm Animal Business
-
Dr. Stacey Ma, PhD
Independent Director
0.01m
Ms. Ellen de Brabander, PhD
Executive Vice President, Innovation and Regulatory Affairs
0.75m
Mr. Rajeev A. Modi
Executive Vice President, U.S. Pet Health and Global Digital Transformation
-
Ms. Grace McArdle
Executive Vice President, Manufacturing and Quality
-
Ms. Shiv O'Neill
Executive Vice President, General Counsel and Corporate Secretary
-

Top 5 shareholders

No. of shares
Dodge & Cox82,920,582
Dodge & Cox Stock Fund55,341,300
FMR Inc53,858,673
Fidelity Management and Research Company53,858,673
PRIMECAP Management Company50,223,535

Director dealings

Action
31 Dec 2024-
27 Dec 2024-
27 Dec 2024-
13 Dec 2024-
13 Dec 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
15 Nov 2024-
15 Nov 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.